The therapy of insulin resistance in other diseases besides type 2 diabetes - Test2 - elhamkhani - TriplyDB

The therapy of insulin resistance in other diseases besides type 2 diabetes

The therapy of insulin resistance in other diseases besides type 2 diabetes

http://www.wikidata.org/entity/Q26822399

about

Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1 Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model.Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus.

P2860

Q26781127-597A17C6-8246-4BE7-B7D8-F7B323923245 Q35982174-05BA0626-29F4-4EEE-94EA-B16BC79D5DAF Q51288592-2A723382-04C3-46A6-B374-C77789EF6B3C

P2860

The therapy of insulin resistance in other diseases besides type 2 diabetes

http://www.wikidata.org/entity/Q26822399

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The therapy of insulin resistance in other diseases besides type 2 diabetes

@ast

The therapy of insulin resistance in other diseases besides type 2 diabetes

@en

The therapy of insulin resistance in other diseases besides type 2 diabetes

@nl

type

label

The therapy of insulin resistance in other diseases besides type 2 diabetes

@ast

The therapy of insulin resistance in other diseases besides type 2 diabetes

@en

The therapy of insulin resistance in other diseases besides type 2 diabetes

@nl

prefLabel

The therapy of insulin resistance in other diseases besides type 2 diabetes

@ast

The therapy of insulin resistance in other diseases besides type 2 diabetes

@en

The therapy of insulin resistance in other diseases besides type 2 diabetes

@nl

P1433

Q26822399-624D382D-569F-4D6B-826F-71B11C09E9D4

P1476

Q26822399-09826716-0947-41C8-98B3-93F5C22CBB06

P2093

Q26822399-558D126E-8805-40C0-946C-4694AD15EBE5

Q26822399-C0D67E5C-2457-4D0B-9742-6EF1C712A5F0

Q26822399-CAE29EED-ED61-46D2-94B3-5FCDE821CFB8

P2860

Q26822399-01600D0E-446E-471E-AA62-7DDCE106E703

Q26822399-0203211D-0686-411B-8E93-1992659D2FC4

Q26822399-04AB3EFE-D8D7-4131-BFB1-AEB184FF4750

Q26822399-0796FD18-0D3A-4E2E-94D5-CEA08034FFE1

Q26822399-0E50CDF3-65FB-4C08-A828-7C64052C89CC

Q26822399-10D13F16-2B33-495C-A208-4C3D46DD8E2E

Q26822399-1B134BBB-5B53-42D3-BC0B-6E89083A977D

Q26822399-1BFB5324-DF2E-44DF-9872-2290915BA13F

Q26822399-1CA4F14B-D1DA-4B59-B87A-20388D83AA61

Q26822399-23B3B79B-537A-43BE-B7EB-97F099647E09

P2888

Q26822399-CE217941-1DC2-4E7B-B4F1-3BA845198092

P304

Q26822399-83195732-DF9B-4B89-9EA6-34F6B2703AD5

P31

Q26822399-8E875450-8F65-450A-A8BD-DA2BD6623E2D

Q26822399-F7BF614A-4079-4D71-99E2-FB6832B884FC

P356

Q26822399-173081FB-62BF-4EBC-9EE1-ADEFD5BDA982

P407

Q26822399-63AE2E63-BAE8-4350-BE9E-D29A225A3F0C

P433

Q26822399-85D4429E-3074-491C-A271-E3451AC84EDE

P478

Q26822399-E6E6641F-FCF2-416F-980A-8296BA2EF59B

P50

Q26822399-7F0EA559-AF8C-42BD-A7C4-3CF183BBB70B

P577

Q26822399-26DC936E-2E4A-49DA-9CCA-62421721BE76

Q26822399-7FECB004-7724-490B-9AA9-66983E598B2D

P5875

Q26822399-10C8A102-6B83-44E2-8444-C7B73D35F463

P6179

Q26822399-9E12F9B3-9902-4592-A4D3-AB96DA364D14

P698

Q26822399-4EAB89E3-8569-4BC7-AAE7-290D80268452

P921

Q26822399-2C74FFA5-9F25-4028-83BB-605C62453977

Q26822399-321772EA-0F2C-4FFF-BA00-18723B86AB85

Q26822399-4DFC8E63-FDAA-4E4A-9C96-BD957744F836

Q26822399-599A6940-50FF-4803-887F-26BEDD95626D

Q26822399-5F458C73-FB50-4006-A69F-C4DCFCB86A34

Q26822399-93D2742B-C6E7-4E39-9003-59131BDA0288

Q26822399-A5CB758E-0FE2-44F1-8C4A-5694554859A1

Q26822399-AE56C162-E89A-4D1A-9F6F-055A2F881820

P932

Q26822399-E1DDB2F0-46CD-46CF-85D9-EE24056771D8

P356

S40519-014-0139-Y

P1433

Eating and Weight Disorders

P1476

The therapy of insulin resistance in other diseases besides type 2 diabetes

@en

P2093

Carlo Maria Rotella

http://www.w3.org/2001/XMLSchema#string

Laura Pala

http://www.w3.org/2001/XMLSchema#string

Valeria Barbaro

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger

Metformin-induced stimulation of adenosine 5' monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells

P2888

s40519-014-0139-y

P304

275-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40519-014-0139-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Ilaria Dicembrini

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264395482

http://www.w3.org/2001/XMLSchema#string

P6179

1011118988

http://www.w3.org/2001/XMLSchema#string

P698

25069836

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

polycystic ovary syndrome

fatty liver disease

physiological phenomena

P932

4143609

http://www.w3.org/2001/XMLSchema#string